Statistics
| Branch: | Revision:

root / mm9 / trackAttr2idx @ master

History | View | Annotate | Download (11.1 kB)

1
10001	MEL (Leukemia (K562 analog))	10001	MEL (Leukemia (K562 analog))
2
10002	ES-E14 (mouse embryonic stem cell line E14)	10002	ES-E14 (mouse embryonic stem cell line E14)
3
10003	CH12 (B-cell lymphoma (GM12878 analog))	10003	CH12 (B-cell lymphoma (GM12878 analog))
4
10004	NIH-3T3 (fibroblast)	10004	NIH-3T3 (fibroblast)
5
10005	Cerebellum	10005	Cerebellum
6
10006	LgIntestine (Large Intestine)	10006	LgIntestine (Large Intestine)
7
10007	Patski (Mouse Embryonic Kidney Fibroblast. As described in Lingenfelter et al., 1998 (Nat Genet. 1998 18:212-3) and Yang et al., 2010 (Genome Res.  2010 20:614-22), PATSKI is a female interspecific mouse fibroblast that was derived from the embryonic  kidney of an M.spretus x C57BL/6J hybrid mouse such that the C57Bl/6J X chromosome (maternal) is  always the inactive X. This is an adherent cell line.)	10007	Patski (Mouse Embryonic Kidney Fibroblast. As described in Lingenfelter et al., 1998 (Nat Genet. 1998 18:212-3) and Yang et al., 2010 (Genome Res.  2010 20:614-22), PATSKI is a female interspecific mouse fibroblast that was derived from the embryonic  kidney of an M.spretus x C57BL/6J hybrid mouse such that the C57Bl/6J X chromosome (maternal) is  always the inactive X. This is an adherent cell line.)
8
10008	GenitalFatPad (Genital Adipose tissue)	10008	GenitalFatPad (Genital Adipose tissue)
9
10009	Liver	10009	Liver
10
10010	A20 (B cell lymphoma line derived from a spontaneous reticulum cell neoplasm)	10010	A20 (B cell lymphoma line derived from a spontaneous reticulum cell neoplasm)
11
10011	Cerebrum	10011	Cerebrum
12
10012	Spleen	10012	Spleen
13
10013	B-cell_(CD19+) (B Cell , CD19+)	10013	B-cell_(CD19+) (B Cell , CD19+)
14
10014	Thymus	10014	Thymus
15
10015	HeadlessEmbryo (Whole embryos with heads removed)	10015	HeadlessEmbryo (Whole embryos with heads removed)
16
10016	Heart	10016	Heart
17
10017	SkMuscle (Skeletal Muscle)	10017	SkMuscle (Skeletal Muscle)
18
10018	B-cell_(CD43-) (mouse spleen B cells, CD43-,CD11b-)	10018	B-cell_(CD43-) (mouse spleen B cells, CD43-,CD11b-)
19
10019	WholeBrain (Whole Brain)	10019	WholeBrain (Whole Brain)
20
10020	416B (myeloid progenitor cells, CD34+)	10020	416B (myeloid progenitor cells, CD34+)
21
10021	FatPad (Adipose tissue)	10021	FatPad (Adipose tissue)
22
10022	T-Naive (Naive T cells: CD4+, CD25-)	10022	T-Naive (Naive T cells: CD4+, CD25-)
23
10023	Lung	10023	Lung
24
10024	Kidney	10024	Kidney
25
10025	Erythrobl (Erythroblast, ter119+ cells from liver)	10025	Erythrobl (Erythroblast, ter119+ cells from liver)
26
10026	G1E (Gata1- erythroid progenitor)	10026	G1E (Gata1- erythroid progenitor)
27
10027	G1E-ER4 (Gata1 restored erythroid cells, differentiation induced by estradiol (E2))	10027	G1E-ER4 (Gata1 restored erythroid cells, differentiation induced by estradiol (E2))
28
10028	Megakaryo (Megakaryocyte)	10028	Megakaryo (Megakaryocyte)
29
10029	10T1/2 (Multipotential cell line that can be converted by 5-azacytidine into three mesodermal stem cell lineages.)	10029	10T1/2 (Multipotential cell line that can be converted by 5-azacytidine into three mesodermal stem cell lineages.)
30
10030	C2C12 (Myoblast cell line derived from thigh muscle of C3H mice after crush injury)	10030	C2C12 (Myoblast cell line derived from thigh muscle of C3H mice after crush injury)
31
10031	Cortex	10031	Cortex
32
10032	BoneMarrow (Bone Marrow)	10032	BoneMarrow (Bone Marrow)
33
10033	Limb	10033	Limb
34
10034	BAT (Brown adipocytes tissue)	10034	BAT (Brown adipocytes tissue)
35
10035	SmIntestine (Small Intestine)	10035	SmIntestine (Small Intestine)
36
10036	MEF (Mouse Embryonic Fibroblast)	10036	MEF (Mouse Embryonic Fibroblast)
37
10037	Placenta	10037	Placenta
38
10038	BMDM (Bone marrow derived macrophage)	10038	BMDM (Bone marrow derived macrophage)
39
10039	OlfactBulb (Olfactory Bulb)	10039	OlfactBulb (Olfactory Bulb)
40
10040	Testis	10040	Testis
41
10041	ES-Bruce4 (mouse embryonic stem cells)	10041	ES-Bruce4 (mouse embryonic stem cells)
42
10042	MammaryGland (Mammary Gland)	10042	MammaryGland (Mammary Gland)
43
10043	Duodenum	10043	Duodenum
44
10044	Adrenal (Adrenal gland)	10044	Adrenal (Adrenal gland)
45
10045	SubcFatPad (Subcutaneous Adipose tissue)	10045	SubcFatPad (Subcutaneous Adipose tissue)
46
10046	Stomach	10046	Stomach
47
10047	Colon	10047	Colon
48
10048	Ovary	10048	Ovary
49
10049	J1 ES cells	10002	J1 mouse embryonic stem cell
50
10050	ATM2E-I13	cell	A-MuLV transformed pro-B cells
51
10051	ZhBTc4 (Undifferentiated mouse embryonic stem cells)	10051	ZhBTc4 (Undifferentiated mouse embryonic stem cells)
52
10052	EPC_(CD117+_CD71+_TER119+) (liver fraction CD117+,CD71+,TER119+)	10052	EPC_(CD117+_CD71+_TER119+) (liver fraction CD117+,CD71+,TER119+)
53
10053	ES-WW6_F1KO (Histone H1c, H1d, H1e triple null mouse embryonic stem cell line derived from ES-WW6 cells.)	10053	ES-WW6_F1KO (Histone H1c, H1d, H1e triple null mouse embryonic stem cell line derived from ES-WW6 cells.)
54
10054	mG/ER (MEL-GATA-1-ER, This is a mouse suspension cell line derived from MEL cells by stable transfection with a GATA-1-ER fusion protein construct as described by Choe et al., 2003 (Cancer Res 63, 6363-6369, 2003). These cells can be terminally differentiated into mature erythroid cells with Β-estradiol treatment)	10054	mG/ER (MEL-GATA-1-ER, This is a mouse suspension cell line derived from MEL cells by stable transfection with a GATA-1-ER fusion protein construct as described by Choe et al., 2003 (Cancer Res 63, 6363-6369, 2003). These cells can be terminally differentiated into mature erythroid cells with Β-estradiol treatment)
55
10055	HindlimbBud (embryo hindlimb buds)	10055	HindlimbBud (embryo hindlimb buds)
56
10056	Retina	10056	Retina
57
10057	THelper-Activated (Activated primary CD4 effector cells, isolated ex vivo)	10057	THelper-Activated (Activated primary CD4 effector cells, isolated ex vivo)
58
10058	EPC_(CD117-_CD71+_TER119+) (liver fraction CD117-,CD71+,TER119+)	10058	EPC_(CD117-_CD71+_TER119+) (liver fraction CD117-,CD71+,TER119+)
59
10059	ES-WW6 (ES-cells isolated from mix of ~20% C57/B6J, ~75% 129/Sv and ~5% SJL strains)	10059	ES-WW6 (ES-cells isolated from mix of ~20% C57/B6J, ~75% 129/Sv and ~5% SJL strains)
60
10060	Mesoderm (axial somatic and lateral plate mesoderm from eviscerated headless, limbless embryos)	10060	Mesoderm (axial somatic and lateral plate mesoderm from eviscerated headless, limbless embryos)
61
10061	EPC_(CD117+_CD71-_TER119-) (liver fraction CD117+,CD71-,TER119-)	10061	EPC_(CD117+_CD71-_TER119-) (liver fraction CD117+,CD71-,TER119-)
62
10062	EPC_(CD117+_CD71+_TER119-) (liver fraction CD117+,CD71+,TER119-)	10062	EPC_(CD117+_CD71+_TER119-) (liver fraction CD117+,CD71+,TER119-)
63
10063	ForelimbBud (embryo forelimb buds)	10063	ForelimbBud (embryo forelimb buds)
64
10064	ES-CJ7 (ES-cells were originally isolated from 129S1/SVImJ mice by Swiatek PJ et al. in 1993 (Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Swiatek PJ, Gridley T. Genes Dev. 1993 Nov,7(11):2071-84.))	10064	ES-CJ7 (ES-cells were originally isolated from 129S1/SVImJ mice by Swiatek PJ et al. in 1993 (Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Swiatek PJ, Gridley T. Genes Dev. 1993 Nov,7(11):2071-84.))
65
10065	TReg-Activated (Activated primary T regulatory cells, isolated ex vivo)	10065	TReg-Activated (Activated primary T regulatory cells, isolated ex vivo)
66
10066	TReg (Regulatory T cells CD4+,CD25+)	10066	TReg (Regulatory T cells CD4+,CD25+)
67
10067	3134 (Mammary)	10067	3134 (Mammary)
68
10068	Fibroblast	10068	Fibroblast
69
10069	MEP (mouse megakaryocyte erythroid progenitor cells with lineages CD16/32 and CD34-)	10069	MEP (mouse megakaryocyte erythroid progenitor cells with lineages CD16/32 and CD34-)
70
10070	FVprogenitor (Friend virus infected murine CD34-,CD133-,Kit+,Sca1+ progenitor cells. Strains which can be used to generate the cells must carry the Fv2 sensitive allele (Fv2s). #PROVISIONAL)	10070	FVprogenitor (Friend virus infected murine CD34-,CD133-,Kit+,Sca1+ progenitor cells. Strains which can be used to generate the cells must carry the Fv2 sensitive allele (Fv2s). #PROVISIONAL)
71
10071	FVLstem (Friend virus infected murine CD34+,CD133+,Kit+,Sca1+ Leukemia stem cells. Strains which can be used to generate the cells must carry the Fv2 sensitive allele (Fv2s). #PROVISIONAL)	10071	FVLstem (Friend virus infected murine CD34+,CD133+,Kit+,Sca1+ Leukemia stem cells. Strains which can be used to generate the cells must carry the Fv2 sensitive allele (Fv2s). #PROVISIONAL)
72
10072	FrontalLobe (Frontal Lobe)	10072	FrontalLobe (Frontal Lobe)
73
10073	Bladder (Urinary Bladder)	10073	Bladder (Urinary Bladder)
74
10074	CNS (Central Nervous System)	10074	CNS (Central Nervous System)
75
148	Hi-C	longrange assay	High-content genome conformation capture
76
149	ChIA-PET	longrange assay	Chromatin interaction analysis by paired-end tag sequencing
77
20001	RnaSeq (Sequencing analysis of RNA expression)	20001	RnaSeq (Sequencing analysis of RNA expression)
78
20002	Input	20002	Input
79
20003	H3K4me3	20003	H3K4me3
80
20004	H3K27me3	20004	H3K27me3
81
20005	H3K4me1	20005	H3K4me1
82
20006	H3K36me3	20006	H3K36me3
83
20007	H3K9me3	20007	H3K9me3
84
20008	GATA1	20008	GATA1
85
20009	TAL1	20009	TAL1
86
20010	GATA2	20010	GATA2
87
20011	CTCF	20011	CTCF
88
20012	PAX5	20012	PAX5
89
20013	Pol2-4H8	20013	Pol2-4H8
90
20014	H3K79me3	20014	H3K79me3
91
20015	H3K4me2	20015	H3K4me2
92
20016	H3ac	20016	H3ac
93
20017	H3K79me2	20017	H3K79me2
94
20018	Pol2	20018	Pol2
95
20019	p300	20019	p300
96
20020	Myogenin	20020	Myogenin
97
20021	USF-1	20021	USF-1
98
20022	MyoD	20022	MyoD
99
20023	NRSF	20023	NRSF
100
20024	TCF12	20024	TCF12
101
20025	CEBPB	20025	CEBPB
102
20026	FOSL1	20026	FOSL1
103
20027	Pol2(phosphoS2)	20027	Pol2(phosphoS2)
104
20028	Max	20028	Max
105
20029	SRF	20029	SRF
106
20030	TCF3	20030	TCF3
107
20031	E2F4	20031	E2F4
108
20032	MafK	20032	MafK
109
20033	JunD	20033	JunD
110
20034	Mxi1	20034	Mxi1
111
20035	c-Myc	20035	c-Myc
112
20036	TBP	20036	TBP
113
20037	c-Myb	20037	c-Myb
114
20038	BHLHE40	20038	BHLHE40
115
20039	NELFe	20039	NELFe
116
20060	DnaseSeq (DNaseI HS Sequencing)	20040	DnaseSeq (DNaseI HS Sequencing)
117
20040	Rad21	20040	Rad21
118
20061	DnaseDgf (DNase Digital Footprinting)	20041	DnaseDgf (DNase Digital Footprinting)
119
20041	GATA-1	20041	GATA-1
120
20042	FLI1	20042	FLI1
121
20062	USF2	20042	USF2
122
20043	HCFC1	20043	HCFC1
123
20063	SMC3	20043	SMC3
124
20044	CHD2	20044	CHD2
125
20064	SIN3A	20044	SIN3A
126
20045	c-Jun	20045	c-Jun
127
20065	Nrf2	20045	Nrf2
128
20046	ZNF384	20046	ZNF384
129
20047	ZC3H11A	20047	ZC3H11A
130
20048	ETS1	20048	ETS1
131
20049	MAZ	20049	MAZ
132
20050	ZNF-MIZD-CP1	20050	ZNF-MIZD-CP1
133
20051	CHD1	20051	CHD1
134
20052	UBF	20052	UBF
135
20053	COREST	20053	COREST
136
20054	GCN5	20054	GCN5
137
20055	ZKSCAN1	20055	ZKSCAN1
138
20056	H3K27me3B	20056	H3K27me3B
139
20057	H3K27ac	20057	H3K27ac
140
20058	H3K36me3B	20058	H3K36me3B
141
20059	H3K9ac	20059	H3K9ac
142
30001	Stanford-m (Snyder - Stanford University)	30001	Stanford-m (Snyder - Stanford University)
143
30002	UW-m (Stamatoyannopoulous - University of Washington)	30002	UW-m (Stamatoyannopoulous - University of Washington)
144
30003	PSU-m (Hardison - Penn State University)	30003	PSU-m (Hardison - Penn State University)
145
30004	Caltech-m (Wold - Califonia Institute of Technology)	30004	Caltech-m (Wold - Califonia Institute of Technology)
146
30005	LICR-m (Ren - Ludwig Institue for Cancer Research)	30005	LICR-m (Ren - Ludwig Institue for Cancer Research)
147
30006	Yale-m (Weissman - Yale University)	30006	Yale-m (Weissman - Yale University)
148
30007	CSHL-m (Gingeras - Cold Spring Harbor Laboratory)	30007	CSHL-m (Gingeras - Cold Spring Harbor Laboratory)